Service

California Clinical Laboratory License Readiness

Last updated: November 2026

California clinical laboratory license readiness means preparing an application and supporting procedures for a state license or registration under California Business and Professions Code (BPC) section 1265, subject to the exceptions in section 1241(b). The California Department of Public Health (CDPH), Laboratory Field Services (LFS), administers the state process alongside federal CLIA certification. Integral Healthcare Solutions (IHS) drafts application materials and procedures for the owners and laboratory director to approve and submit.

What does California require beyond a CLIA certificate?

Subject to section 1241(b)’s exceptions, BPC 1265 requires a state license for moderate or high complexity testing and registration for waived or provider-performed microscopy (PPM) testing. Sources opened November 5, 2026: BPC 1265, 1241, 1209, the CDPH LFS CLIA page and the CDPH LFS fee page.

License or registration

A laboratory performing tests classified as moderate or high complexity under CLIA must obtain a license, and none issues unless the laboratory and its personnel meet the CLIA requirements for those tests (1265(a)(1)). For waived or PPM testing, section 1265(a)(2) requires registration on department-provided forms and a finding of compliance with the chapter, its regulations and the applicable CLIA certificate requirements.

Who applies, and what the department must be satisfied of

The owners and the laboratory directors apply before the laboratory opens (1265(b)). If owners are not directors, the license or registration issues jointly; both are severally and jointly responsible for maintenance, conduct and violations of the chapter and its regulations. The application includes owner and director names, laboratory name and location, tests and annual procedure counts excluding quality control, quality assurance and proficiency testing, kits, methods, equipment, and the education, training and experience of directing, supervising and testing personnel. It also identifies providers performing PPM tests and includes other relevant information CDPH requires. Under 1265(c), the department does not issue until it is satisfied that the laboratory will be operated within the spirit and intent of the chapter, that the owners and directors are each of good moral character, and that the license will not conflict with the interests of public health.

Locations

Each location needs its own license or registration. Section 1265(d) allows a single license or registration for a laboratory without a fixed location, using its designated primary-site address; for a not-for-profit or federal, state or local government laboratory performing limited public health testing of no more than a combination of 15 moderately complex or waived tests per license; and, at the owners’ discretion, for commonly owned locations within one street and city address. Laboratories within a hospital, in contiguous buildings on the same campus and under common direction, may file one application or multiple applications.

Who needs this, and what triggers it?

This service is for laboratories preparing an initial application or reviewing how changes in testing, ownership, directorship or locations affect their state license or registration. Section 1241(a) applies the chapter to all clinical laboratories in California or receiving biological specimens originating in California, except as 1241(b) provides; 1241(b) lists exceptions, such as forensic-only testing.

How does the application process work, and how is the license kept?

StepWhat the CDPH page says
1. State licenseApply through the LFS online system, upload federal Form CMS 116 in it and pay the California fee there.
2. Federal fee couponCDPH describes a CMS fee coupon after 2 to 3 weeks, with the CLIA number and amount due. Federal fees are paid online.
3. Federal certificateFor waiver or PPM, payment precedes certificate issuance, posting and patient testing. For compliance or accreditation, LFS forwards the application to its onsite licensure section; a Certificate of Registration is a prerequisite. CDPH describes a compliance survey fee coupon after 6 to 9 months, based on estimated volume in the compliance application, with inspection scheduled after payment. An approved accreditation organization conducts the accreditation inspection.

The federal side is on IHS’s CLIA laboratory start-up page. CDPH says to renew the California license online every year; federal CLIA renewal is processed separately.

A license or registration is valid for one year unless revoked or suspended; it is revoked automatically 30 days after a major change of laboratory directorship or ownership, and the laboratory must submit a completed application for a new one within those 30 days or stop practicing (1265(e)(1)). If practice continues during the 30 days after a major directorship change and before automatic revocation, the owner may appoint an interim director meeting the chapter and CLIA requirements. Appointment must occur within five business days of the major change, with written notice to CDPH within five business days of appointment (1265(e)(2)).

Owners or their delegated representatives, and directors, must notify CDPH in writing within 30 days of ownership, directorship, name or location changes, including added or removed owners or directors. Both current and new owners are responsible for ownership-change notice; failure to notify within 30 days of any director change causes automatic revocation (1265(g)).

How IHS helps

IHS assesses gaps against the governing requirements, maps documents and evidence to them, and drafts application materials and procedures for the laboratory director and client clinicians to approve. A mock file review identifies remaining tasks before the owners submit. Thomas G. Goddard, JD, PhD, leads the work in IHS’s Compliance Services line, with compliance program development as the companion.

What IHS drafts

What you supply

The owners, the director, test menu and volumes, methods, personnel licenses, your CLIA application, the fee, the filing and every answer to CDPH.

The real limit

IHS does not decide a test’s CLIA complexity, choose methods, direct the laboratory or file anything. Who may direct a laboratory is set by BPC 1209 (see the FAQ). This page summarizes selected statutes and CDPH application guidance; it is not a complete account of California laboratory requirements.

What to have ready

Links reflect the November 5, 2026 reading.

  1. Your test list and classifications: BPC 1265(a), current text.
  2. Annual test counts excluding quality control, quality assurance and proficiency testing: BPC 1265(b), current text.
  3. Owner and director names under BPC 1265(b), current text, and director qualifications under BPC 1209(a)–(b), current text.
  4. Kits, methods, equipment and directing, supervising and testing personnel qualifications: BPC 1265(b), current text.
  5. Location addresses and facts supporting any exception: BPC 1265(d), current text.
  6. Form CMS 116 for upload: CDPH CLIA application guidance.
  7. Renewal, major-change application and notice calendars, including interim-director deadlines: BPC 1265(e), (g), current text.

The free introductory call is where IHS walks through this list with you.

How does the state license compare with a federal certificate or accreditation?

State licensing and federal certification have separate roles.

ItemIssued byCovers
California license or registrationCDPH LFS under BPC 1265State requirements for covered laboratories, including those receiving California-origin specimens, subject to section 1241(b). Renewed yearly.
Federal CLIA certificateCMS, with the State AgencyFederal quality standards for testing human specimens. Renewed separately.
AccreditationA CMS-approved accreditation organizationA route to a federal certificate of accreditation. It does not replace the California license.

Related IHS pages: ACHC, CAP, CAP versus COLA and New York’s separate program.

What does it cost?

CDPH publishes the state fees (page opened November 5, 2026): registration is 155 dollars for waived and 235 dollars for PPM. A license fee depends on annual moderate and high complexity test volume, excluding calculations and quality control, quality assurance and proficiency testing assays. The first eight tiers for an initial or renewal fee (renewal expiring on or after January 1, 2026) are below; a secondary site under 1265(d) is 28 dollars. Verify current fees with CDPH.

Annual test volumeFee, in dollars
Less than 2,001335
2,001 to 10,0001,100
10,001 to 25,0001,800
25,001 to 50,0002,200
50,001 to 75,0002,700
75,001 to 100,0003,300
100,001 to 500,0004,000
500,001 to 1,000,0007,200

The fee page lists higher tiers. A license expiring in 2026 renews at the 2025 fee, followed by a notice for the difference based on the 2026 fees.

IHS scopes each engagement after a free introductory call.

What this is not

Frequently asked questions

Does a California laboratory need a state license in addition to CLIA?

Generally, California requires a state license for moderate or high complexity testing and registration for waived or PPM testing, alongside federal CLIA certification. Section 1241(b) provides exceptions to the chapter’s coverage.

What does a waived-test laboratory need from California?

Section 1265(a)(2) requires a laboratory under a CLIA waiver or PPM certificate to register with the department. The CDPH schedule lists 155 dollars for waived and 235 dollars for PPM; for licenses expiring in 2026, its notice describes paying the 2025 renewal fee first and receiving a later notice for the difference. Verify current fees with CDPH.

In what order are the state license and the federal certificate obtained?

CDPH describes applying through the LFS online system with CMS 116, paying the state fee and receiving the state license first. Its federal steps then differ for waiver/PPM and compliance/accreditation; the latter requires a Certificate of Registration before the final certificate. CDPH describes a federal fee coupon after 2 to 3 weeks, not a guaranteed final-certificate date.

How often is the California license renewed?

Every year. A license or registration is valid for one year unless revoked or suspended (1265(e)(1)), and CDPH says to renew online.

What happens if the director or owner changes?

A major change of directorship or ownership revokes the license automatically 30 days later, and the laboratory must file a completed new application within those 30 days or stop practicing (1265(e)(1)). Section 1265(g) separately requires written notice within 30 days of ownership, directorship, name or location changes, including added or removed owners or directors; both current and new owners are responsible for ownership-change notice. Failure to notify within 30 days of any director change causes automatic revocation.

Who can be the laboratory director?

Under BPC 1209(a), a licensed physician and surgeon; or, only for waived tests, the other listed professionals (clinical laboratory scientist, limited clinical laboratory scientist, naturopathic doctor, or, within stated limits, optometrist, dentist or pharmacist-in-charge); or, by exception, a certified nurse-midwife directing a laboratory performing only waived or provider-performed microscopy tests within the nurse-midwifery certificate; or a person licensed to direct a clinical laboratory under the chapter. Section 1209(h) adds an acute care hospital rule. Section 1209(b)(1) also requires a person under 1209(a)(1) or (3), identified as the CLIA director of a moderate or high complexity laboratory, to meet CLIA director qualifications for the type and complexity of tests offered.

Does a laboratory outside California need the license?

Section 1241(a) applies the chapter to laboratories receiving biological specimens that originate in California, except as 1241(b) provides. Out-of-state laboratories should confirm their applicable license or registration process directly with CDPH.

Does IHS deal with CDPH?

No. The owners and director file in the LFS online system and answer CDPH. IHS does not contact or correspond with CDPH or CMS for the laboratory.

Recent changes

  • Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities

    · Substance Abuse and Mental Health Services Administration

    Full title: Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies (Notice; FR Doc. 2026-22321)

    Substance Abuse and Mental Health Services Administration states: “The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.”

    Checked

  • REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment

    · Centers for Medicare & Medicaid Services

    Full title: REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits (QSO-18-14-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-18-14-CLIA, "Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits", on October 16, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments: Provide Input on Proposed Changes by December 7

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS is seeking input on proposed changes to the rules implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Comment period, in the source's words: “Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Checked

  • REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance

    · Centers for Medicare & Medicaid Services

    Full title: REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance (QSO-23-15-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-23-15-CLIA, "REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance", on October 14, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments of 1988 (CLIA)

    · Centers for Medicare & Medicaid Services

    Full title: Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes (Proposed rule; FR Doc. 2026-20613)

    Centers for Medicare & Medicaid Services states: “This proposed rule would amend the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to allow for virtual access under the CLIA certificate of the primary testing laboratory that generated the data, with the exception of the subspecialty of cytology, and the use of digital images for gynecologic cytology proficiency testing. This proposed rule also includes proposed changes to personnel qualification requirements and other proposed changes pertaining to SARS-CoV-2 reporting requirements, certificate requirements, test reporting requirements, enforcement requirements, public consultation requirements, and editorial and technical updates. These proposed updates aim to strengthen the Federal oversight of clinical laboratories and ensure accurate and reliable patient test results while adapting to modern technological capabilities and industry needs, including workforce shortages.”

    Checked

More: Laboratories · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session